-
Mashup Score: 0
ASCO 2023 patient reported outcomes (PROs) from the CheckMate 9ER trial, health-related quality of life (HRQoL) of IMDC risk-based patient subgroups, advanced renal cell cancer (RCC), nivolumab plus cabozantinib versus sunitinib.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2Highlights in Renal Cell Carcinoma From ASCO 2022 - 2 year(s) ago
Dr Brian Rini, of Vanderbilt University, reports on key studies in renal cell cancer from ASCO 2022, including results from the EVEREST and CheckMate 9ER trials, and data on a novel AXL inhibitor.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
.@brian_rini reports on key studies in #renalcellcancer from #ASCO22, including results from the EVEREST and CheckMate 9ER trials, and data on a novel AXL inhibitor. #kidneycancer https://t.co/H8mRI0VMnC https://t.co/J8qJsj5ugC
-
-
Mashup Score: 0Medscape Log In - 2 year(s) ago
Free Unlimited Access and Benefits: Latest medical news and expert perspectives Essential drugs, diseases, and clinical tools Free CME and professional online education
Source: login.medscape.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
.@brian_rini reports on key studies in #renalcellcancer from #ASCO22, including results from the EVEREST and CheckMate 9ER trials, and data on a novel AXL inhibitor. https://t.co/qxqCdVHhAk https://t.co/OWEjsToacE
-
-
Mashup Score: 3
MLS – Evolving Treatments for the Oncology Practice | Las Vegas, NV. Online registration by Cvent
Source: web.cvent.comCategories: Hem/Oncs, Latest HeadlinesTweet-
⭐️How does leading #RenalCellCancer Expert Dr. @TiansterZhang decide which treatment to give for 1st line metastatic clear cell renal cell? Join us to find out below. Free registration 👇 https://t.co/U72E7nUqFw @OncoAlert https://t.co/CHQ4PWaA1L
-
-
Mashup Score: 0
Welcome! You are invited to join a meeting: How do i personalize immunotherapy treatment in aRCC. After registering, you will receive a confirmation email about joining the meeting.
Source: Zoom Video CommunicationsCategories: Hem/Oncs, Latest HeadlinesTweet-
Webinar meeting on "How do I personalize immunotherapy in advanced RCC" #cancertreatment #renalcellcancer #immunotherapy Today at 7.30pm to 9pm. webinar link https://t.co/yqIJeE6kOY https://t.co/89swGFpjrw
-
-
Mashup Score: 6ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2021 - 3 year(s) ago
3-4 December 2021, Lugano, Switzerland
Source: www.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
ESMO Preceptorship on Metastatic #BladderCancer & #KidneyCancer: exploring systemic treatment in #urothelialcarcinoma & #renalcellcancer, molecular pathology, side effects & more 📍Lugano 🗓️ 3-4 Dec 👉 Apply by 19 Oct: https://t.co/14yQ0gpHMj #blcsm #kcsm @AlbigesL @tompowles1 https://t.co/xOBZXFT8N7
-
-
Mashup Score: 2
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Source: The OncologistCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR) #PhaseII #TRAXAR #Axitinib #RenalCellCancer #RCC #Endoglin #TRC105 #Carotuximab https://t.co/PYIrdZJvbG https://t.co/ycZ3zv2Fgk
-
-
Mashup Score: 4EAU Guidelines: Renal Cell Carcinoma | Uroweb - 3 year(s) ago
The European Association of Urology (EAU) Renal Cell Cancer (RCC) Guidelines Panel has compiled these clinical guidelines to provide urologists with evidence-based information and recommendations for the management of RCC.
Source: UrowebCategories: Latest Headlines, UrologyTweet-
In localised renal cell cancer, use integrated prognostic systems or nomograms to assess risk of recurrence #renalcellcancer #eauguidelines https://t.co/YkI1tGJp1t
-
-
Mashup Score: 2
ASCO GU 2021 Genitourinary Cancers Symposium NAXIVA: A Phase II Neoadjuvant Study of Axitinib for Reducing Extent of Venous Tumor Thrombus in Clear Cell Renal Cell Cancer with Venous Invasion, levels of venous tumor thrombus extension, NAXIVA trial design, toxicity and safety profile of axitinib, axitinib neoadjuvant treatment
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
#NAXIVA Phase II neoadjuvant study of axitinib for reducing extent of venous tumor thrombus in clear cell #RenalCellCancer with venous invasion. Presented by Grant Stewart, MD, PhD @Cambridge_Uni. #GU21 written coverage by @zklaassen_md @GACancerCenter > https://t.co/tL8iFqSVBN https://t.co/aRr3pz7MER
-
-
Mashup Score: 6EAU Guidelines: Renal Cell Carcinoma | Uroweb - 4 year(s) ago
The European Association of Urology (EAU) Renal Cell Cancer (RCC) Guidelines Panel has compiled these clinical guidelines to provide urologists with evidence-based information and recommendations for the management of RCC.
Source: UrowebCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @Uroweb: Use a coaxial technique when performing a renal tumour biopsy #renalcellcancer #eauguidelines https://t.co/YkI1tGJp1t
-
Health-Related QoL of risk-based patient subgroups with advanced #RenalCellCancer treated with nivolumab + cabozantinib vs sunitinib in the #CheckMate9ER trial. Presented by David Cella, PhD @LurieCancer. #ASCO23 coverage by @RKSayyid @UofT > https://t.co/zovlIOtm1r @nu_ipham https://t.co/I0Mv0MtoeU